MANKIND PHARMA
|
MANKIND PHARMA Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹2,525 Cr | ₹2,399 Cr | ₹1,671 Cr | ₹1,975 Cr | ₹1,692 Cr |
| Adjustment | ₹602 Cr | ₹212 Cr | ₹298 Cr | ₹31 Cr | ₹-5.66 Cr |
| Changes In working Capital | ₹-146 Cr | ₹-18 Cr | ₹167 Cr | ₹-586 Cr | ₹-95 Cr |
| Cash Flow after changes in Working Capital | ₹2,980 Cr | ₹2,594 Cr | ₹2,136 Cr | ₹1,419 Cr | ₹1,591 Cr |
| Cash Flow from Operating Activities | ₹2,413 Cr | ₹2,152 Cr | ₹1,813 Cr | ₹920 Cr | ₹1,137 Cr |
| Cash Flow from Investing Activities | ₹-12,683 Cr | ₹-2,082 Cr | ₹-1,054 Cr | ₹-1,369 Cr | ₹-1,222 Cr |
| Cash Flow from Financing Activities | ₹10,233 Cr | ₹5.27 Cr | ₹-740 Cr | ₹605 Cr | ₹-7.81 Cr |
| Net Cash Inflow / Outflow | ₹-37 Cr | ₹76 Cr | ₹19 Cr | ₹155 Cr | ₹-93 Cr |
| Opening Cash & Cash Equivalents | ₹382 Cr | ₹305 Cr | ₹283 Cr | ₹127 Cr | ₹220 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | ₹-9.40 Cr | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | ₹67 Cr | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | ₹1.31 Cr | ₹1.17 Cr | ₹2.32 Cr | ₹0.48 Cr | ₹0.38 Cr |
| Closing Cash & Cash Equivalent | ₹404 Cr | ₹382 Cr | ₹305 Cr | ₹283 Cr | ₹127 Cr |
Compare Cashflow Statement of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹92,956.4 Cr | 1.4% | -7.9% | -13% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹439,378.0 Cr | 2.8% | 6.7% | 2.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,996.0 Cr | 1.9% | -0.5% | 6.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,959.0 Cr | 0.1% | 3.4% | 15.8% | Stock Analytics | |
| CIPLA | ₹123,666.0 Cr | 1.8% | -3.2% | 2.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,008.0 Cr | 2.7% | 0.4% | 3.4% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 1.4% |
-7.9% |
-13% |
| SENSEX | 0.6% |
1.3% |
7% |
You may also like the below Video Courses